Biosimilars can improve access to treatment for patients who might not have been able to access biologics previously, explained Laura Wingate, executive vice president, Education, Support, & Advocacy, Crohn’s & Colitis Foundation. However, there are concerns that cost savings from biosimilars aren’t reaching the patients, she added.TranscriptWhat are the key barriers to access to biosimilars […]
